Skip to main content

and
  1. Article

    Open Access

    CAR T cells and T cells phenotype and function are impacted by glucocorticoid exposure with different magnitude

    Chimeric antigen receptor (CAR) T cell therapy is associated with high risk of adverse events. Glucocorticoids (GCs) are cornerstone in the management of high-grade cytokine release syndrome (CRS) and immune e...

    Thomas Poiret, Sara Vikberg, Esther Schoutrop in Journal of Translational Medicine (2024)

  2. Article

    Open Access

    Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy

    Intratumoral injection of oncolytic viruses (OVs) shows promise in immunotherapy: ONCOS-102, a genetically engineered OV that encodes Granulocyte–Macrophage Colony-Stimulating Factor (GM-CSF) demonstrated effi...

    Neshat Saffarzadeh, Emelie Foord, Eoghan O’Leary in Journal of Translational Medicine (2024)

  3. Article

    Open Access

    Linear epitope map** of the humoral response against SARS-CoV-2 in two independent African cohorts

    Profiling of the antibody responses to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) proteins in African populations is scarce. Here, we performed a detailed IgM and IgG epitope map** study ag...

    Inès Vigan-Womas, Jean-Louis Spadoni, Thomas Poiret, Fabien Taïeb in Scientific Reports (2023)

  4. Article

    Open Access

    Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer

    Patients with brain tumor or pancreatic cancer exhibit the poorest prognosis, while immune fitness and cellular immune exhaustion impacts their survival immensely. This work identifies differences in the immun...

    Zhenjiang Liu, Thomas Poiret, Qingda Meng, Martin Rao in Journal of Translational Medicine (2018)

  5. Article

    Open Access

    NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma

    The prognosis for patients with glioblastoma is grim. Ex vivo expanded tumor-associated antigen (TAA)-reactive T-cells from patients with glioma may represent a viable source for anticancer-directed cellular t...

    Zhenjiang Liu, Thomas Poiret, Oscar Persson in Cancer Immunology, Immunotherapy (2018)

  6. Article

    Open Access

    IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy

    Zhenjiang Liu, Qingda Meng, Markus Maeurer in Journal for ImmunoTherapy of Cancer (2015)

  7. Article

    Open Access

    Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma

    Qingda Meng, Zhenjiang Liu, Markus Maeurer in Journal for ImmunoTherapy of Cancer (2015)

  8. Article

    Open Access

    Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy

    Qingda Meng, Elena B Rangelova, Liu zhenjiang in Journal for ImmunoTherapy of Cancer (2014)

  9. Article

    Open Access

    A fast assay to gauge for TAA-reactive T cells in PBMCS from patients with pancreatic cancer

    Elena B Rangelova, Qingda Meng, Liu zhenjiang in Journal for ImmunoTherapy of Cancer (2014)

  10. Article

    Open Access

    Expression of TAAs in glioblastoma and expansion of anti-TAA -reactive T cells

    Ernest Dodoo, Liu zhenjiang, Bartek Jiri in Journal for ImmunoTherapy of Cancer (2014)

  11. Article

    Open Access

    Rapid expansion of TILs from patients with glioma and recognition of autologous tumor

    Liu Zhenjiang, Qingda Meng, Oscar Persson in Journal for ImmunoTherapy of Cancer (2014)

  12. Article

    Open Access

    Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults

    Interleukin 7 (IL-7) signals via the IL-7 receptor (IL-7R) and drives homeostatic T-cell proliferation in patients after allogeneic hematopoietic stem cell transplantation (aHSCT).

    Thomas Poiret, Lalit Rane, Mats Remberger, Birgitta Omazic in BMC Immunology (2014)